Curaleaf Holdings, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Curaleaf Holdings, Inc. - overview

Established

2010

Location

Wakefield, MA, US

Primary Industry

Consumer Services

About

Curaleaf Holdings, Inc. is a leading cannabis company that focuses on cultivating and distributing a wide array of cannabis products for both medicinal and recreational use across the United States. Curaleaf was founded in 2010 in Wakefield, US, by Boris Jordan and Cameron Forni. The company produces cannabis products and operates multiple dispensaries, serving consumers in states like California, Florida, and Massachusetts.


Bridget Byrne and Joe Bayern currently hold CEO positions, guiding the company through its growth and expansion. Curaleaf specializes in a diverse range of cannabis products designed to cater to both recreational and medicinal users. The company's core offerings include high-quality flower, vapes, edibles, and tinctures, each developed to meet specific consumer needs. Their premium flower is curated from top-shelf genetics and is available in various formats such as whole flower, popcorn buds, pre-ground shake, and pre-rolls.


Curaleaf has introduced innovative products like Fruit Stiq, an all-in-one vape featuring a selection of fruity flavors, and JAMS, a line of cannabis-infused treats. These products aim to enhance the user experience, whether for pain relief, relaxation, or enjoyment. Curaleaf's products are available across multiple states in the U. S.


, including but not limited to California, Florida, and Massachusetts, thereby servicing a wide geographical market that includes both medical and adult-use consumers. Curaleaf generates revenue through direct sales of its cannabis products to consumers, as well as through partnerships with retailers and wholesalers. Transactions typically occur in retail dispensaries, where customers can purchase individual products like their signature pre-rolls or edibles. While specific pricing details are not disclosed, the company’s product offerings are designed to provide a range of options that appeal to various consumer budgets.


Curaleaf's revenue structure is primarily focused on B2C sales, enabling consumers to easily access their products in a retail setting. The company also emphasizes social responsibility through initiatives such as B NOBLE, which aims to raise awareness and funds for individuals affected by cannabis-related legal issues, further reinforcing its commitment to ethical business practices.


Primary Industry

Consumer Services

Sub Industries

Consumer Services, Alternative Medicine

Website

www.curaleaf.com

Verticals

Cannabis/Medical Marijuana, Manufacturing

Total Amount Raised

Subscriber access only

Curaleaf Holdings, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedHMS Health, LLC-
Add-onCompletedHMS Processing LLC-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.